T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
+$2.09B |
| 2 |
Rockwell Automation
ROK
|
+$1.46B |
| 3 |
Autodesk
ADSK
|
+$1.19B |
| 4 |
Citigroup
C
|
+$1.11B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.23B |
| 2 |
GE Aerospace
GE
|
+$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.17B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Fidelity National Information Services
FIS
$35.1B
| $60.3M | 0.01% |
812,874
+11,655
| +1% | +$865K |
|
677
Immunovant
IMVT
$2.92B
| $60.2M | 0.01% |
1,862,043
+259,481
| +16% | +$8.38M |
|
678
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.79B
| $59.7M | 0.01% |
385,338
+17,553
| +5% | +$2.72M |
|
679
Digital Realty Trust
DLR
$59.2B
| $59.6M | 0.01% |
413,917
-307,275
| -43% | -$44.3M |
|
680
Oscar Health
OSCR
$5.04B
| $59.2M | 0.01% |
3,978,152
+2,409,160
| +154% | +$35.8M |
|
681
Option Care Health
OPCH
$4.75B
| $59M | 0.01% |
1,760,482
+23,676
| +1% | +$794K |
|
|
XYZ
682
Block, Inc.
XYZ
$45.5B
| $59M | 0.01% |
697,523
-142,101
| -17% | -$12M |
|
683
Pliant Therapeutics
PLRX
$103M
| $59M | 0.01% |
3,959,088
+173,172
| +5% | +$2.58M |
|
684
Agios Pharmaceuticals
AGIO
$2.12B
| $58.9M | 0.01% |
2,012,993
+388,381
| +24% | +$11.4M |
|
685
Disc Medicine
IRON
$2.12B
| $58.8M | 0.01% |
944,213
+353,382
| +60% | +$22M |
|
686
Occidental Petroleum
OXY
$45.3B
| $58.8M | 0.01% |
904,081
+8,863
| +1% | +$576K |
|
687
Blue Owl Capital
OWL
$12.3B
| $58.5M | 0.01% |
3,101,594
-3,981
| -0.1% | -$75.1K |
|
688
Prudential Financial
PRU
$37.5B
| $58.5M | 0.01% |
498,247
+2,001
| +0.4% | +$235K |
|
689
FTAI Aviation
FTAI
$17.1B
| $58.4M | 0.01% |
867,963
+813,311
| +1,488% | +$54.7M |
|
|
NEE.PRR
690
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| – | – |
0
| – | -$56M |
|
691
Live Nation Entertainment
LYV
$40.1B
| $57.8M | 0.01% |
546,372
-111,192
| -17% | -$11.8M |
|
692
Unilever
UL
$155B
| $57.3M | 0.01% |
1,141,878
+214,635
| +23% | +$10.8M |
|
693
Relay Therapeutics
RLAY
$702M
| $57.1M | 0.01% |
6,879,597
-1,701,570
| -20% | -$14.1M |
|
694
Abercrombie & Fitch
ANF
$4.44B
| $57M | 0.01% |
454,550
+141,788
| +45% | +$17.8M |
|
695
CorVel
CRVL
$4.52B
| $56.9M | 0.01% |
648,963
-5,502
| -0.8% | -$482K |
|
696
Corteva
CTVA
$49.3B
| $56.7M | 0.01% |
983,916
+4,498
| +0.5% | +$259K |
|
697
Watsco
WSO
$16.1B
| $56.7M | 0.01% |
131,149
+443
| +0.3% | +$191K |
|
698
Estee Lauder
EL
$31.5B
| $56.6M | 0.01% |
367,218
+5,915
| +2% | +$912K |
|
699
Dick's Sporting Goods
DKS
$20.6B
| $56.2M | 0.01% |
249,958
-34,457
| -12% | -$7.75M |
|
700
Synchrony
SYF
$28.3B
| $56.1M | 0.01% |
1,300,576
+342,979
| +36% | +$14.8M |
|